No Data
No Data
A Quick Look at Today's Ratings for Black Diamond Therapeutics(BDTX.US), With a Forecast Between $11 to $18
Buy Rating on Black Diamond Therapeutics: Promising Phase 2 Results for BDTX-1535 in NSCLC Treatment
Black Diamond Theraptcs Is Maintained at Overweight by Piper Sandler
US Equity Futures Gain as Investors Search for Fresh Catalysts After Fed Rate Cut
Sector Update: Health Care
Market-Moving News for September 23rd
No Data
No Data